Comparing different identification approaches for the depth of anesthesia using BIS measurements

Depth of anesthesia is usually quantified by the Bispectral Index (BIS) and refers to both loss of consciousness, resulting from the administration of a hypnotic like propofol, and inhibition of pain, resulting from the administration of an analgesic like remifentanil. This paper addresses the mathematical modeling of the joint effect of propofol and remifentanil in the depth of anesthesia, using BIS measurements. Two models and identification strategies are considered. The first model is based on standard pharmacokinetic/pharmacodynamic models and the associated identification strategy corresponds to the application of a hybrid method. The second model has a minimal number of parameters and the associated identification strategy corresponds to the application of a prediction error method. These two approaches are tested and compared on real data.

[1]  Jiann-Shing Shieh,et al.  Genetic fuzzy modelling and control of bispectral index (BIS) for general intravenous anaesthesia. , 2006, Medical engineering & physics.

[2]  J. Bruhn,et al.  Pharmacodynamic Interaction between Propofol and Remifentanil Regarding Hypnosis, Tolerance of Laryngoscopy, Bispectral Index, and Electroencephalographic Approximate Entropy , 2004, Anesthesiology.

[3]  Hugo Alonso,et al.  A hybrid method for parameter estimation and its application to biomedical systems , 2008, Comput. Methods Programs Biomed..

[4]  Le Yi Wang,et al.  Decision-Oriented Multi-Outcome Modeling for Anesthesia Patients , 2010, The open biomedical engineering journal.

[5]  M M da Silva,et al.  Online nonlinear identification of the effect of drugs in anaesthesia using a minimal parameterization and BIS measurements , 2010, Proceedings of the 2010 American Control Conference.

[6]  Nassib G. Chamoun,et al.  An introduction to bispectral analysis for the electroencephalogram , 1994, Journal of Clinical Monitoring.

[7]  Thomas W. Schnider,et al.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development , 1997 .

[8]  S. Shafer,et al.  The Influence of Method of Administration and Covariates on the Pharmacokinetics of Propofol in Adult Volunteers , 1998, Anesthesiology.

[9]  S L Shafer,et al.  Response Surface Model for Anesthetic Drug Interactions , 2000, Anesthesiology.

[10]  E. Gepts,et al.  Disposition of Propofol Administered as Constant Rate Intravenous Infusions in Humans , 1987, Anesthesia and analgesia.

[11]  N. Morton,et al.  Pharmacokinetic model driven infusion of propofol in children. , 1991, British journal of anaesthesia.

[12]  W. Haddad,et al.  Drug dosing control in clinical pharmacology , 2005, IEEE Control Systems.

[13]  M. Struys,et al.  Comparison of Closed-loop Controlled Administration of Propofol Using Bispectral Index as the Controlled Variable versus “Standard Practice” Controlled Administration , 2001, Anesthesiology.

[14]  E. Furutani,et al.  A hypnosis control system using a model predictive controller with online identification of individual parameters , 2005, Proceedings of 2005 IEEE Conference on Control Applications, 2005. CCA 2005..

[16]  J. Bruhn,et al.  Correlation of Approximate Entropy, Bispectral Index, and Spectral Edge Frequency 95 (SEF95) with Clinical Signs of “Anesthetic Depth” during Coadministration of Propofol and Remifentanil , 2003, Anesthesiology.